Skip to main content
Nucleic Acids Research logoLink to Nucleic Acids Research
. 1998 May 1;26(9):2069–2074. doi: 10.1093/nar/26.9.2069

The pro-oligonucleotide approach: solid phase synthesis and preliminary evaluation of model pro-dodecathymidylates.

G Tosquellas 1, K Alvarez 1, C Dell'Aquila 1, F Morvan 1, J J Vasseur 1, J L Imbach 1, B Rayner 1
PMCID: PMC147525  PMID: 9547261

Abstract

A modified phosphoramidite method has been designed for the solid-phase synthesis of two dodecathymidine phosphotriesters and two dodecathymidine thionophosphotriesters. In these analogs, each internucleoside link bears an S -acyl-2-thioethyl (Me-SATE or tBu-SATE) group removable upon esterase activation. Efficient synthesis of these lipophilic analogs was achieved thanks to the use of a photolabile linker anchored to the solid support in combination with thymidine-3'- O -phosphoramidites having a SATE group in place of the regular 2-cyanoethyl one. Both dodecathymidine phosphotriester and thionophosphotriester having S -acetyl-2-thioethyl groups were found to be stable in the presence of snake venom and calf spleen phosphodiesterases whereas, upon incubation in CEM cell extracts, they were selectively hydrolyzed to the anionic parent dodecathymidylate and dodecathymidine phosphorothioate, respectively. In addition, Me-SATE-protected dodecathymidine thionophosphotriester was stable in mouse and human sera as well as in human gastric juice. These results depict the potential of SATE-protected oligonucleotides as prodrugs of antisense oligonucleotides.

Full Text

The Full Text of this article is available as a PDF (84.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agrawal S., Zhang R. Pharmacokinetics of oligonucleotides. Ciba Found Symp. 1997;209:60–78. doi: 10.1002/9780470515396.ch6. [DOI] [PubMed] [Google Scholar]
  2. Aldridge W. N. The esterases: perspectives and problems. Chem Biol Interact. 1993 Jun;87(1-3):5–13. doi: 10.1016/0009-2797(93)90019-u. [DOI] [PubMed] [Google Scholar]
  3. Alul R. H., Singman C. N., Zhang G. R., Letsinger R. L. Oxalyl-CPG: a labile support for synthesis of sensitive oligonucleotide derivatives. Nucleic Acids Res. 1991 Apr 11;19(7):1527–1532. doi: 10.1093/nar/19.7.1527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Crooke S. T., Graham M. J., Zuckerman J. E., Brooks D., Conklin B. S., Cummins L. L., Greig M. J., Guinosso C. J., Kornbrust D., Manoharan M. Pharmacokinetic properties of several novel oligonucleotide analogs in mice. J Pharmacol Exp Ther. 1996 May;277(2):923–937. [PubMed] [Google Scholar]
  5. Gloaguen V., Plancke Y., Strecker G., Vebret L., Hoffmann L., Morvan H. Structural characterization of three aldobiuronic acids derived from the capsular polysaccharide produced by the thermophilic cyanobacterium Mastigocladus laminosus. Int J Biol Macromol. 1997 Aug;21(1-2):73–79. doi: 10.1016/s0141-8130(97)00044-5. [DOI] [PubMed] [Google Scholar]
  6. Lefebvre I., Périgaud C., Pompon A., Aubertin A. M., Girardet J. L., Kirn A., Gosselin G., Imbach J. L. Mononucleoside phosphotriester derivatives with S-acyl-2-thioethyl bioreversible phosphate-protecting groups: intracellular delivery of 3'-azido-2',3'-dideoxythymidine 5'-monophosphate. J Med Chem. 1995 Sep 29;38(20):3941–3950. doi: 10.1021/jm00020a007. [DOI] [PubMed] [Google Scholar]
  7. Mentlein R., Heymann E. Hydrolysis of ester- and amide-type drugs by the purified isoenzymes of nonspecific carboxylesterase from rat liver. Biochem Pharmacol. 1984 Apr 15;33(8):1243–1248. doi: 10.1016/0006-2952(84)90176-x. [DOI] [PubMed] [Google Scholar]

Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press

RESOURCES